Trademark: NEXT GENERATION RADIOLIGANDS
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
NEXT GENERATION RADIOLIGANDS
Click here to search for trademarks similar to NEXT GENERATION RADIOLIGANDS
Proof of use for NEXT GENERATION RADIOLIGANDS
We do not have any records of a proof of use for NEXT GENERATION RADIOLIGANDS at this moment.
Click here to add a proof of use for NEXT GENERATION RADIOLIGANDS
Possible trademark infringements of NEXT GENERATION RADIOLIGANDS
Basic Information about NEXT GENERATION RADIOLIGANDS
- Serial Number
- 97664916
- Filing Date
- 06 Nov 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of NEXT GENERATION RADIOLIGANDS on the blockchain with WikiTrademarks.io.
- First use of NEXT GENERATION RADIOLIGANDS anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns NEXT GENERATION RADIOLIGANDS?
1. POINT Biopharma Inc. Indianapolis IN
2. POINT Biopharma Inc. Indianapolis IN
Correspondent
- John R. Rudolph Eli Lilly and Company
- Lilly Corporate Center
- www.lilly.com
- Indianapolis, IN 46285
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io